triazoles has been researched along with efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Álvarez, S; Clemente, MI; Díaz, L; García-Alonso, D; Martínez-Bonet, M; Moreno, S; Muñoz, E; Muñoz-Fernández, MÁ | 1 |
1 other study(ies) available for triazoles and efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination
| Article | Year |
|---|---|
Antiretroviral drugs do not interfere with bryostatin-mediated HIV-1 latency reversal.
Topics: Adult; Anti-Retroviral Agents; Bryostatins; CD4-Positive T-Lymphocytes; Cells, Cultured; Cyclohexanes; Drug Interactions; Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; HIV-1; Humans; Male; Maraviroc; Middle Aged; Triazoles; Virus Latency | 2015 |